| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 |
# |
Score |
Template |
Links and tools | %id | First |
MAADFETSNRRWLDKLPRNLTDSARSLHPRTLVAAIVVGLITGVLGAGFKSAVNNMLQWRSQLAQILAPIPPLAWLVTALISGGMVALSFWLMKRFAPDTSGSGIPQIEGHLEGKLPLVWQRVLPIKLVGGFLSLGAGMLAGFEGPTIQMGGSIGQMTGGWFKATQENQRILIAVGAGAGLATAFNAPLAGVALIGEEMHPRFRSQTLAYHSLLFGCVMATIILRMIRGQSAIISLTEFKRVPLDSLWMFIILGILFGVMGYTFNRGLFKVLDWFDRLPPLATKWKGFLLGSIIGILSLFPLPLTDGGDNAVLWAFNSQSHFSTLILVFCGRFLLTLICYGSGAIGGIFAPMLGIASIVSVAMARHFHLLFPSQIPEPAVMAIAGMGALVAATVRAPLTAILLTIEMTDNYFVILPLLVTCLVASVVAEALGGKPIYTVLLERTLAKQNRG | Last |
1 | -79.100 | PF00654.20; A6VKP8_ACTSZ/67-405; Voltage gated chloride channel |
ali follow.. |
20 | 8 | ............................................................................................IGWYSVHRYGKKLLSVKQGLDNPQQGVPFFKTVGHALLQIITVGLGSPLGREVAPREMSVAFGSAWVRKAGLNDTDAKLILACASGAGLTAVYNVPLASTIFILETMVLSISTR--SLGAALVTVVLSTCVSRFFLGDLVQYDKVTPFAINTELLIFSAIIGMLIPFVVQGFRRSTQHVPFLQRT--DKRIIPVAVLLFSLIGFISIYQPEILGNGKPGNQLTFGEMINWSESLQLMALKWLAVLFALAAGAYGGLITPSMMLGSTFAYSLAIGWNALFP--QLSLEGAAIIGACVFLGIMQKMPFTSIVFLLELTRNAEVLMPLTLAMGAAIATDR...................... |
339 |
2 | -7.320 | PF03553.14; Q9KBE2_BACHD/142-433; Na+/H+ antiporter family |
ali follow.. |
11 | 1 | .........................................................................................................................................SLTFGLKAPYILIPAGYGLLFHSIIADEMTANMLFPGLAMVVGLLVAINDAQVDEQSTINETAATEEREFFSLKHVLTLLAIVAALT-------------------VQILFQSLVLGALTGIILMFAFRVVPFHRGDEVMNEGVKMMGTIAFVMLIASGYATVLKET--GAVEQLVASTSSSLGSHSFLIALVLIFIGLVITMGIGSSFGTIPIIAALYVPLCAAVGF----------------PLATAALIGTAGV-SPASDSTLGPTSGLNADGKVPTFLHYNIPLIV........................ |
289 |
3 | -6.970 | PF05505.12; NCAP_EBOZM/19-734; Ebola nucleoprotein |
ali follow.. |
10 | 5 | ..................................................................................................KILTAGLSVQQGIVRQRVIPVYQVNNLEEICQLIIAFEAGVDFQESADSFLLMLCLHHAYQ-------------------GDYKLFLESGAVKYLFRFEVKKRDGVKRLEELLPAVSSGKNIKRTLAAM-------PEEETTEANAGQFLSFASLFLPKLVVG---EQGLIQYPTAWQSVGHMMVIFRLMRTNFLIKFLLIHQGMHMVAGHDANDAVISNSVAQARFSGLLIVKTVLDHILQKTER-GVRLHPLARTAKVKNEV---------NSFKAALSSLAKHGEYAPFARLLNLSGVNNL-----HGLFPQLSAIALG--VATAHGSTLAGVNVGEQYQQLREAATEA. |
332 |
4 | -6.840 | PF04147.12; S3ECN4_GLAL2/48-905; Nop14-like family |
ali follow.. |
8 | 452 | ......................................................................................................ESHEQLLEITKGISLLDLPTVVLCNFAISLIDHISYLANQSKLPPFSVLETLIRHIHSLAKSYPKEIANSFRSHLEQFNESRSLSPTPGDLIILTAIGTVFPTSHQVVTPALL--TMGRYLALK-------------IPQNLFDY-----------AVGAYMCTLCLQYQILSKRYI-------PEVISFIENSLCTLAPSRMLILPGNFERSKAEGESLKVALLDTNLSLLGVASETWSGKAS-IFEPSLKI-------LKHLGNKTCRPLLPSNTQKSLTSLTKKITTALSNSVLNLELHHHRPLAIKTSIPKFEETFNPDKHYD--DRDRAEAAKLRKEYKQEKKG |
814 |
5 | -6.690 | PF07235.11; Q8U4X9_AGRFC/2-84; Protein of unknown function (DUF1427 topsan) |
ali follow.. |
19 | 2 | ...........................................................................................................................................................................................................................................................................................................................................................VYLLSLGAGLLVGIVYS-----LLNVRSPAPPVIALVGLLGILVGEQIIPFARSII................................................ |
52 |
6 | -6.670 | PF05977.13; Q92SW7_RHIME/14-535; Transmembrane secretion effector |
ali follow.. |
13 | 17 | ........................................................................................IASLASNFGGLIQAVGAAWLMTSISQSVNMVALVQASTSLPIMLFSLVSGALADNFD-AQSFMLAVSALLTVCAYYGIVTPWLLLIFTFLLGCGTALNNP-SWQASVGDMVPRDDLPAAVALNSMGFN--LTRSVGPAIGG-----------------IVAAAGAAAAFAANTLSYFAILFALARWKPVAPENRLPRETLGRAVSAGL------YVAMSPNIGKVLVRGFAFGLSASAILALLPLVARDLVGGGPLTYGVMLGAFGVGAIGGALLSARLREFLTSEAIVRYAFAGFAFSALVTAISPQAWLTCLVLA-VSGACWVLALSLFNTTVQLSTPRWVVGRSLYQTMT.......... |
352 |
7 | -5.870 | PF15484.6; CB074_HUMAN/39-194; Domain of unknown function (DUF4642 topsan) |
ali follow.. |
11 | 13 | ................................................................................................VPCTDANGGVDCAAAKVVTSNPEDHERILMQVMNLNVPMRPGILVQRQSKEV-LATPLENRRDMEAEEENQIQKIHTSVTRTPSVVESQKRPLKGVTFSREVIVVDLGNEYPT.................................................................................................................................................................................................................................................. |
144 |
8 | -5.830 | PF04018.13; U4K7K7_9VIBR/13-258; Domain of unknown function (DUF368 topsan) |
ali follow.. |
12 | 1 | ..............................................................................................................................................................................MGAADVVPGVSGGTIAFITGIYDTLLESIRRVNPSIIGIWKREGFKAAFDHI------------------GLFLITLFSGIILSIL--TLAKLISWL------LVEHPIPLWSFFFGLILISVVHVLKQVEKKNIVTGVFLLLGVGFAYTITVVSPLQMSLNIFIAGMIAICAMILPGIS-GSFILLLLGMYGPILAAAKGLQIDVLMLFMLGCVVGILSFSHVLSWLLKNFRDYTLTFLTGLMLGTLPK........................... |
227 |
9 | -5.790 | PF02990.16; C4JNI4_UNCRE/63-607; Endomembrane protein 70 |
ali follow.. |
13 | 271 | ..............................................................................................................................................................................SGWKLVHGDVFRCPKHPLLLSV------LGNGAQLFMMTGLTVLFALF----------LLSPSNRGFLGTAILIIYTFLGFIGGYVASRTYKSF-------EAWKRLIIATPLILPAIIFSVFFFL---------NFILWVKGASGAVPFTTMIVIVLIWFV-----------ISVPLSVGGSWIGFKQPALEGPTIPRQIPPAVGSLRLVPSTLIAGFF--PFAAIFV--ELYFIMNSL--LFLCYGLMIMMSAMTTVLLVYFLLCAED....... |
510 |
10 | -5.730 | PF13782.6; R5EV98_9CLOT/28-140; Stage V sporulation protein AB |
ali follow.. |
8 | 22 | ...........................................................................................................................................................................................................................................................................................................................................................LYETVIILGGVLGNILDIYEFPIYMGPYIGTLFICVFGLVGIFVGCLVMSLAETLKTLPVISRRIHLAVGLQYLIFALAAGKMAGS.................. |
108 |